Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
IQVIA Holdings, Inc. Common Stock
(NY:
IQV
)
271.83
+6.95 (+2.62%)
Official Closing Price
Updated: 7:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IQVIA Holdings, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
5 revealing analyst questions from IQVIA’s Q3 earnings call
October 29, 2026
IQVIA delivered an 8% year-over-year revenue increase in Q3, with results that outpaced Wall Street expectations and prompted a positive market reaction. Man...
Via
StockStory
Topics
Artificial Intelligence
Earnings
IQV Q3 deep dive: AI adoption and clinical momentum drive growth, guidance raised
October 29, 2026
Clinical research company IQVIA (NYSE: IQV) reported Q3 2026 results topping the market’s revenue expectations, with sales up 8% year on year to $4.43 billio...
Via
StockStory
Topics
Artificial Intelligence
What IQVIA (IQV) Said on Its Q3 Earnings Call
↗
October 27, 2026
IQVIA (NYSE:IQV) reported third-quarter results that exceeded the high end of its guidance ranges, supported by accelerating organic growth in its Commercial Solutions and R&D Solutions businesses,...
Via
MarketBeat
Topics
Earnings
IQVIA (IQV) Q3 2026 Earnings Call Transcript
↗
October 27, 2026
Revenue hit $4.4 billion with 8% growth; net new bookings surged 15% year over year.
Via
The Motley Fool
Topics
Earnings
IQVIA HOLDINGS INC (NYSE:IQV) Sets Up for Breakout With Strong Technical Ratings
↗
October 20, 2026
Via
Chartmill
S&P 500 Premarket Movers: Royal Caribbean, S&P Global Gain; Xylem, Sherwin-Williams Fall
↗
October 27, 2026
Via
Chartmill
Topics
Stocks
IQVIA’s (NYSE:IQV) Q3 2026: beats on revenue
October 27, 2026
Clinical research company IQVIA (NYSE: IQV) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 8% year on year to $4.43 bi...
Via
StockStory
Topics
Artificial Intelligence
IQVIA Reports Third-Quarter 2026 Results
October 27, 2026
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA (IQV) Q3 earnings report preview: what to look for
October 25, 2026
Clinical research company IQVIA (NYSE: IQV) will be reporting results this Tuesday before market open. Here’s what to expect. IQVIA beat analysts’ revenue ex...
Via
StockStory
IQVIA (NYSE:IQV) Nears Breakout With 10/10 Technical Strength and 9/10 Setup
↗
September 23, 2026
Via
Chartmill
1 Large-Cap Stock to Research Further and 2 We Avoid
October 19, 2026
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...
Via
StockStory
3 Low-Volatility Stocks with Questionable Fundamentals
October 16, 2026
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on hi...
Via
StockStory
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
October 15, 2026
AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034 New York, NY – October 15,...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
October 15, 2026
AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034
From
FN Media
Via
GlobeNewswire
IQVIA Selects Veeva Clinical Operations Applications
October 13, 2026
From
IQVIA
Via
Business Wire
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
October 07, 2026
From
IQVIA
Via
Business Wire
IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions
October 07, 2026
From
IQVIA
Via
Business Wire
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
October 06, 2026
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via
StockStory
Topics
Stocks
IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026
September 29, 2026
From
IQVIA
Via
Business Wire
IQVIA Announces Pricing of Senior Notes
September 09, 2026
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA Announces Offering of Senior Notes
September 09, 2026
From
IQVIA Holdings Inc.
Via
Business Wire
IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings?
September 08, 2026
The past six months have been a windfall for IQVIA’s shareholders. The company’s stock price has jumped 50%, hitting $267.77 per share. This was partly thank...
Via
StockStory
1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm
September 04, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
September 03, 2026
From
IQVIA
Via
Business Wire
Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment
August 30, 2026
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...
Via
StockStory
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
August 27, 2026
From
IQVIA
Via
Business Wire
2 Large-Cap Stocks with Exciting Potential and 1 That Underwhelm
August 25, 2026
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
Via
StockStory
IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
August 20, 2026
From
IQVIA
Via
Business Wire
Exploring the top movers within the S&P500 index during today's session.
↗
August 20, 2026
Via
Chartmill
Thursday's session: top gainers and losers in the S&P500 index
↗
August 20, 2026
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today